← NEOGENOMICS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $12.5m | $12.8m | $9.8m | $173.0m | $228.7m | $316.8m | $263.2m | $342.5m | $367.0m | $159.6m | |
| Prepaid Expense and Other Assets, Current | $4.5m | $4.2m | — | — | — | — | — | — | — | — | |
| Inventory, Net | $6.3m | $7.5m | $8.7m | $14.4m | $29.5m | $23.4m | $24.3m | $24.2m | $26.7m | $28.6m | |
| Assets, Current | $78.8m | $85.0m | $103.7m | $290.7m | $448.7m | $681.5m | $605.3m | $596.8m | $596.0m | $376.3m | |
| Property, Plant and Equipment, Net | $34.0m | $36.5m | $60.9m | $64.2m | $85.9m | $109.5m | $102.5m | $92.0m | $94.1m | $84.8m | |
| Goodwill | $147.0m | $147.0m | $197.9m | $198.6m | $211.1m | $527.1m | $522.8m | $522.8m | $522.8m | $524.3m | |
| Intangible Assets, Net (Excluding Goodwill) | — | — | $140.0m | $126.6m | $120.7m | $442.3m | $408.3m | $373.1m | $339.7m | $286.5m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $26.5m | $45.8m | $102.2m | $96.1m | $91.8m | $79.6m | $78.4m | |
| Other Assets, Noncurrent | $174k | $689k | $2.5m | $2.8m | $4.5m | $7.2m | $5.1m | $4.7m | $5.9m | $9.4m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $55.5m | $60.4m | $76.9m | $94.2m | $106.8m | $112.1m | $119.7m | $131.2m | $150.5m | $159.2m | |
| Assets | $337.1m | $343.3m | $505.0m | $709.5m | $988.3m | $1.9b | $1.7b | $1.7b | $1.6b | $1.4b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $3.4m | $5.0m | $6.9m | $6.6m | $5.6m | $3.4m | $4.8m | |
| Accounts Payable, Current | $16.8m | $10.4m | $17.8m | $19.6m | $25.0m | $17.9m | $20.5m | $20.3m | $21.6m | $23.1m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $24.0m | $42.3m | $72.3m | $69.0m | $67.9m | $60.8m | $62.8m | |
| Long-term Debt, Excluding Current Maturities | $91.9m | $91.1m | $92.9m | — | — | — | — | — | $340.3m | $341.9m | |
| Long-term Debt, Current Maturities | $3.8m | $3.8m | $7.9m | — | $0 | — | — | — | $200.8m | $0 | |
| Liabilities, Current | $38.1m | $35.1m | $60.9m | $63.9m | $73.2m | $87.2m | $89.9m | $96.3m | $301.2m | $88.3m | |
| Deferred Income Tax Liabilities, Net | — | $6.7m | $22.5m | $15.6m | $5.4m | $55.5m | $34.8m | $24.3m | $21.5m | $18.2m | |
| Other Liabilities, Noncurrent | — | — | $3.1m | $3.6m | $4.1m | $14.0m | $13.1m | $13.0m | $11.8m | $12.1m | |
| Deferred Tax Liabilities, Net | $15.0m | $6.3m | $22.1m | $15.6m | $5.4m | $55.2m | $34.8m | $24.3m | $21.5m | $18.2m | |
| Liabilities | $150.5m | $137.8m | $184.6m | $202.1m | $294.0m | $761.5m | $742.0m | $739.7m | $735.7m | $523.3m | |
| Commitments and Contingencies | — | — | — | $0 | — | — | — | — | — | — | |
| Stockholders’ equity: | |||||||||||
| Retained Earnings (Accumulated Deficit) | ($52.5m) | ($57.5m) | ($51.3m) | ($11.4m) | ($7.2m) | ($14.8m) | ($159.1m) | ($247.1m) | ($325.8m) | ($433.8m) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | $274k | ($579k) | ($1.6m) | $10k | ($638k) | ($3.9m) | ($1.7m) | ($206k) | $4k | |
| Additional Paid in Capital, Common Stock | $216.1m | $230.0m | $372.2m | $520.3m | $701.4m | $1.1b | $1.2b | $1.2b | $1.2b | $1.3b | |
| Stockholders' Equity Attributable to Parent | $163.7m | $172.9m | $320.4m | $507.4m | $694.3m | $1.1b | $998.0m | $941.5m | $902.3m | $836.6m | |
| Liabilities and Equity | $337.1m | $343.3m | $505.0m | $709.5m | $988.3m | $1.9b | $1.7b | $1.7b | $1.6b | $1.4b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.